ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Watchlist Price Alert

Omeros Corporation (OMER)

NASDAQ: OMER · Real-Time Price · USD

3.17

-0.03 (-0.94%)

At close: Jun 30, 2025, 11:26 AM

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

OMER News

3 days ago - Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA - businesswire.com
6 days ago - Omeros Announces Webcast Details for Annual Meeting of Shareholders - businesswire.com
20 days ago - Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - benzinga.com
27 days ago - Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER) - zacks.com
34 days ago - Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster - seekingalpha.com
46 days ago - Omeros Corporation (OMER) Q1 2025 Earnings Conference Call Transcript - seekingalpha.com
46 days ago - Omeros Corporation Reports First Quarter 2025 Financial Results - businesswire.com
49 days ago - Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025 - businesswire.com
49 days ago - Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 - businesswire.com
55 days ago - FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date - businesswire.com

Add to Watchlist

✕

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Discord Bot
Free Newsletter
Get Support

Website

Login
FAQ
Sitemap
Learning Center
Affiliate Program

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Imprint

© 2025 Stocknear. All rights reserved.